Health
Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma – News-Medical.Net
Younger patients with specific genetic subtypes of non-GCB DLBCL, called MCD and N1, had an exceptional response to the treatment…
Younger patients with specific genetic subtypes of non-GCB DLBCL, called MCD and N1, had an exceptional response to the treatment combination.
New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen…
Continue Reading
-
General16 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News22 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General21 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Business24 hours agoBell Potter names the best ASX shares to buy in October